Newsletter | May 20, 2024

05.20.24 -- Balancing Technology And The Human Touch


Meaningful Industry Change Means Balancing Tech And Human Touch

Technology and AI/ML are advancing at an unprecedented pace, and we must not lose sight of our industry's core: human-to-human interaction.


Market Trends, Partnerships Driving Orphan Drug Innovation

This report includes expert guidance on navigating development and manufacturing challenges with orphan drugs, with insights on how drug sponsors of all sizes work with CDMOs to achieve their goals.

Are Drugs Becoming More Lipophilic Over Time?

Get a deeper look into how drug lipophilicity has evolved over time, its impact on drug development, and the need for new technology to enable new more complex drugs.

Pharma R&D Annual Review 2024

As we reflect on the past year, our insights serve as a beacon for driving innovation, fostering collaboration, and ultimately, advancing the collective goal of improving global healthcare outcomes.

Real-Time Live Cell Imaging In Successful ADC Development

Learn how the visualization of critical cellular responses can enable live-cell imaging to indicate effective payload delivery, increasing the potential of identifying clinically viable ADC leads.

Navigating AAV Vector Manufacturing

Due to its therapeutic impact on a wide range of diseases and disorders, adeno-associated virus (AAV) gene therapy is one of the most promising advances in modern medicine.


Article Submission Guidelines Life Science Leader

Think you have a good idea for an article that Life Science Leader readers would find valuable?  Read these guidelines first before submitting your idea or your article to our editorial director. 

Connect With Life Science Leader: